New program aims to boost HIV testing and care for teen girls in zambia

NCT ID NCT03995953

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a package of services to help adolescent girls and young women in Zambia get regular HIV testing, prevention, and treatment. The program included education sessions, youth clubs, and special clinics offering integrated care. Over 2,000 girls aged 10–20 took part, but the COVID-19 pandemic prevented collection of some key follow-up data.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

SHIELD intervention (education, youth clubs, caregiver support) and integrated wellness care clinics

What this could lead to

If successful, this approach could provide a practical model to improve HIV testing, prevention, and treatment among adolescent girls in high-risk settings.

What could go wrong

The trial was completed but key data on retention and viral load were not collected due to COVID-19, limiting conclusions. The interventions are behavioral and depend on local implementation, so results may not apply broadly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Population Council

    Lusaka, Zambia